[go: up one dir, main page]

SG10202002593SA - Activated bifidobacteria and methods of use thereof - Google Patents

Activated bifidobacteria and methods of use thereof

Info

Publication number
SG10202002593SA
SG10202002593SA SG10202002593SA SG10202002593SA SG10202002593SA SG 10202002593S A SG10202002593S A SG 10202002593SA SG 10202002593S A SG10202002593S A SG 10202002593SA SG 10202002593S A SG10202002593S A SG 10202002593SA SG 10202002593S A SG10202002593S A SG 10202002593SA
Authority
SG
Singapore
Prior art keywords
methods
activated bifidobacteria
bifidobacteria
activated
Prior art date
Application number
SG10202002593SA
Inventor
David Kyle
David Mills
Samara Freeman-Sharkey
Original Assignee
Evolve Biosystems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55761664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG10202002593S(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Evolve Biosystems Inc filed Critical Evolve Biosystems Inc
Publication of SG10202002593SA publication Critical patent/SG10202002593SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/04—Preserving or maintaining viable microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG10202002593SA 2014-10-24 2015-10-23 Activated bifidobacteria and methods of use thereof SG10202002593SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462068553P 2014-10-24 2014-10-24
US201562133243P 2015-03-13 2015-03-13

Publications (1)

Publication Number Publication Date
SG10202002593SA true SG10202002593SA (en) 2020-05-28

Family

ID=55761664

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10202002593SA SG10202002593SA (en) 2014-10-24 2015-10-23 Activated bifidobacteria and methods of use thereof
SG11201703298SA SG11201703298SA (en) 2014-10-24 2015-10-23 Activated bifidobacteria and methods of use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201703298SA SG11201703298SA (en) 2014-10-24 2015-10-23 Activated bifidobacteria and methods of use thereof

Country Status (10)

Country Link
US (2) US10716816B2 (en)
EP (1) EP3209308B1 (en)
CN (2) CN107249611A (en)
AU (3) AU2015335601A1 (en)
BR (1) BR112017008284A8 (en)
CA (1) CA2965663C (en)
DK (1) DK3209308T3 (en)
MX (1) MX382478B (en)
SG (2) SG10202002593SA (en)
WO (1) WO2016065324A1 (en)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
EP3209308B1 (en) 2014-10-24 2022-08-03 Evolve Biosystems Inc. Activated bifidobacteria and methods of use thereof
EP3881680B8 (en) 2014-10-31 2025-02-26 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
MX2017008449A (en) 2014-12-23 2017-10-12 4D Pharma Res Ltd PIRINE POLYPEPTIDE AND IMMUNE MODULATION.
SI3065748T1 (en) 2014-12-23 2018-05-31 4D Pharma Research Limited A bacteroides thetaiotaomicron strain and its use in reducing inflammation
EP4494482A3 (en) * 2015-03-05 2025-04-23 Société des Produits Nestlé S.A. Compositions for use in improving stool consistency or frequency in infants or young children
CN107847533A (en) * 2015-03-13 2018-03-27 进化生物系统股份有限公司 Compositions for metabolizing or sequestering free sugar monomers and uses thereof
MA41010B1 (en) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprising bacterial strains
MA41060B1 (en) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprising bacterial strains
TWI733676B (en) 2015-06-15 2021-07-21 英商4D製藥研究有限公司 Compositions comprising bacterial strains
SG10201912324XA (en) 2015-06-15 2020-02-27 4D Pharma Res Ltd Compositions comprising bacterial strains
BR112017026564B1 (en) 2015-06-15 2022-05-03 4D Pharma Research Limited BACTERIAL CELLS, USES, AND COMPOSITION
HUE036362T2 (en) 2015-11-20 2018-07-30 4D Pharma Res Ltd Preparations containing bacterial strains
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
SI3313423T1 (en) 2016-03-04 2019-07-31 4D Pharma Plc Compositions comprising bacterial blautia strains for treating visceral hypersensitivity
SG11201807809XA (en) 2016-03-11 2018-10-30 Evolve Biosystems Inc A transient commensal microorganism for improving gut health
BR112018076927A2 (en) 2016-07-01 2019-04-02 Evolve Biosystems, Inc. method to facilitate maturation of the mammalian immune system
TW201821093A (en) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 Composition comprising a bacterial strain
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
WO2018215760A1 (en) 2017-05-22 2018-11-29 4D Pharma Research Limited Compositions comprising bacterial strains
TW201907931A (en) 2017-05-24 2019-03-01 英商4D製藥研究有限公司 Composition comprising a bacterial strain
PT3638271T (en) 2017-06-14 2021-01-05 4D Pharma Res Ltd Compositions comprising bacterial strains
CN115813955A (en) 2017-06-14 2023-03-21 4D制药研究有限公司 Compositions comprising bacterial strains
IL292373A (en) 2017-06-14 2022-06-01 4D Pharma Res Ltd Compositions comprising a bacterial strain of the genus megasphera and uses thereof
WO2019008104A1 (en) * 2017-07-07 2019-01-10 Nestec S.A. Human milk fortifier
CN107365705B (en) * 2017-07-14 2021-01-12 江苏微康生物科技有限公司 Freeze-drying protective agent for oil-soluble probiotic freeze-dried powder and application thereof
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. Methods and compositions for treatment of microbiome-associated disorders
EP3681521A4 (en) * 2017-09-13 2021-05-19 Evolve Biosystems Inc. METABOLOMIC REVIEW OF MAMMAL INFANTS
WO2019143871A1 (en) 2018-01-17 2019-07-25 Evolve Biosystems, Inc. Activation of conditionally-expressed oligosaccharide pathways during fermentation of probiotic strains
CN113164532A (en) * 2018-05-30 2021-07-23 进化生物系统股份有限公司 H5 functional Bifidobacterium longum subspecies infantis compositions and methods of use
WO2019232513A1 (en) * 2018-06-01 2019-12-05 Evolve Biosystems, Inc. Compositions and methods to promote host defense and stimulate, expand, and/or reset t cell repertoires
US20210161924A1 (en) * 2018-06-19 2021-06-03 Evolve Biosystems, Inc. Novel oligosaccharides for use in prebiotic applications
CN113164526A (en) 2018-07-19 2021-07-23 潘德勒姆治疗公司 Methods and compositions for microbial implantation
EP3927171A4 (en) 2019-02-22 2022-11-30 Aquero Canada Ltd. Fortified milk compositions and their processes of preparation
JP2023519115A (en) * 2020-03-20 2023-05-10 グリコム・アクティーゼルスカブ Method for providing solid HMO product and solid HMO product obtained thereby
CN111826324A (en) * 2020-08-05 2020-10-27 厦门惠盈动物科技有限公司 Preparation method of lactobacillus rhamnosus powder
BR112023002758A2 (en) * 2020-08-14 2023-05-02 Prolacta Bioscience Inc COMPOSITIONS OF HUMAN MILK OLIGOSACCHARIDES FOR USE WITH BACTERIOTHERAPIES
CN114568516A (en) * 2020-11-30 2022-06-03 内蒙古伊利实业集团股份有限公司 Composition containing bifidobacterium longum subsp. infantis and breast milk oligosaccharide and application thereof
CN114568520A (en) * 2020-11-30 2022-06-03 内蒙古伊利实业集团股份有限公司 Infant formula powder containing bifidobacterium longum subspecies infantis and application thereof
EP4258901B1 (en) 2020-12-11 2025-09-24 DSM IP Assets B.V. Improved prebiotic formulations
IT202100024911A1 (en) * 2021-09-29 2023-03-29 Univ Degli Studi Di Napoli Federico Ii Dipartimento Di Fisica Ettore Pancini PREBIOTIC BASED ON DELACTOSED "SCOTTA" FOR THE PREVENTION AND MANAGEMENT OF INTESTINAL DYSIBIOSIS
CN116407484B (en) * 2021-12-29 2025-08-26 嘉必优生物技术（武汉）股份有限公司 A skin care composition for repairing skin barrier and its application

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716615A (en) 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
RU2180915C1 (en) 2001-04-28 2002-03-27 Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского Consortium of bifidobacteria and lactobacilli used for preparing bacterial preparations, ferments for fermented-milk foodstuffs, fermented and nonfermented foodstuffs, biologically active supplements designated for correction of microflora in children in age below 3 years
RU2373769C2 (en) * 2003-10-24 2009-11-27 Н.В. Нютрисиа Synbiotic composition for children
US20070082087A1 (en) * 2005-10-06 2007-04-12 Schweitzer Biotech Company Ltd. Fermented milk products containing bifidobacterium longum and isomalto oligosaccharide and the process for producing the same
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US20110165127A1 (en) 2006-06-09 2011-07-07 Fabiola Masri Dairy-derived probiotic compositions and uses thereof
EP2069520A4 (en) * 2006-09-15 2010-05-05 Univ California GENETIC SEQUENCES OF BIFIDOBACTERIA AND THEIR USE
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
EP2072052A1 (en) * 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
UA32462U (en) 2008-02-14 2008-05-12 Харьковский Национальный Медицинский Университет Method for evaluation of effectiveness of correction of distortions of intestines microbiotsenosis in children of early age with atopic dermatitis
CA2658440C (en) * 2008-04-04 2016-08-23 Kraft Foods Global Brands Llc Dairy composition with probiotics and anti-microbial system
EP2143341A1 (en) * 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
EP2303294A1 (en) * 2008-05-27 2011-04-06 Nestec S.A. Probiotics to improve gut microbiota
ES2566496T3 (en) * 2008-11-11 2016-04-13 Alimentary Health Limited Bifidobacterium longum
CN102300575A (en) 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 Human Milk Permeate Compositions And Methods Of Making And Using Same
US9649380B2 (en) 2009-01-12 2017-05-16 Pfizer Italia S.R.L. Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin
US8198872B2 (en) 2009-03-10 2012-06-12 Honeywell International, Inc. Starter-generator with improved excitation
US7888062B1 (en) * 2010-02-01 2011-02-15 Microbios, Inc. Process and composition for the manufacture of a microbial-based product
MX2012009306A (en) 2010-02-19 2012-09-12 Glycom As Production of 6'-o-sialyllactose and intermediates.
EP3369739A1 (en) 2010-07-12 2018-09-05 The Regents of The University of California Bovine milk oligosaccharides
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
EP2454948A1 (en) * 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula
EP2465507A1 (en) * 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating skin diseases
CA2822660C (en) 2010-12-31 2021-09-07 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides
PT2672844E (en) * 2011-02-10 2015-02-04 Nestec Sa MODIFICATION OF BIFIDOBACTERIA GROWTH USING A COMBINATION OF OLIGOSACÁRIDOS IDENTIFIED IN HUMAN MILK
US9579353B2 (en) 2011-06-10 2017-02-28 Prothera, Inc. Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes
US9327016B2 (en) * 2012-02-14 2016-05-03 The Regents Of The University Of California Enzymes and methods for cleaving N-glycans from glycoproteins
US10165788B2 (en) 2013-06-17 2019-01-01 The Regents Of The University Of California Methods and compositions for improved digestion of milk oligosaccharides
EP3209308B1 (en) 2014-10-24 2022-08-03 Evolve Biosystems Inc. Activated bifidobacteria and methods of use thereof
ES2862176T3 (en) 2014-12-12 2021-10-07 Univ California Reduction of milk glucans and their breakdown products in the intestine of the newborn

Also Published As

Publication number Publication date
BR112017008284A8 (en) 2023-04-11
CA2965663C (en) 2023-04-04
AU2015335601A1 (en) 2017-06-01
WO2016065324A1 (en) 2016-04-28
EP3209308A4 (en) 2018-06-27
BR112017008284A2 (en) 2017-12-19
EP3209308B1 (en) 2022-08-03
DK3209308T3 (en) 2022-10-03
CN107249611A (en) 2017-10-13
MX2017005260A (en) 2018-01-30
AU2021204822A1 (en) 2021-08-05
EP3209308A1 (en) 2017-08-30
MX382478B (en) 2025-03-13
NZ731722A (en) 2024-11-29
US20170304375A1 (en) 2017-10-26
US10716816B2 (en) 2020-07-21
CN114376234A (en) 2022-04-22
CA2965663A1 (en) 2016-04-28
US20200397837A1 (en) 2020-12-24
SG11201703298SA (en) 2017-05-30
AU2024264651A1 (en) 2025-03-13

Similar Documents

Publication Publication Date Title
SG11201703298SA (en) Activated bifidobacteria and methods of use thereof
IL250415B (en) Anti-pdl- antibodies and methods of use thereof
IL289976A (en) Oxysterols and methods of use thereof
IL256710A (en) Oxysterols and methods of use thereof
GB201421847D0 (en) Dispensers and methods of use thereof
SG10201500986TA (en) Catheter devices and related methods
HUE061672T2 (en) Glycan-interacting compounds and methods of use
EP3157528A4 (en) Oxysterols and methods of use thereof
IL253234A0 (en) Methods of transdifferentiation and methods of use thereof
GB201404470D0 (en) Therapeutic methods and materials
PT3089971T (en) Compounds and methods of use
GB201417048D0 (en) Occupancy-control device and methods of use
SG11201704473WA (en) New methods and uses
EP3152281A4 (en) Defoaming agent and associated methods of use
ZA201703398B (en) Pharmaceutical composition and methods
SG11201605915WA (en) Furo-3-carboxamide derivatives and methods of use
IL251335A0 (en) Piperidinylpyrazolopyrimidinones and their use
ZA201606450B (en) Compounds and their methods of use
GB2558547B (en) Actuatable paddle and methods of use
IL248554A0 (en) Variants of dr3 and use thereof
GB201509977D0 (en) Dispensers and methods of use thereof
HK40106692A (en) Oxysterols and methods of use thereof
GB201403697D0 (en) Compounds and methods of use
PL3229772T3 (en) 6-aryl-9-glycosylpurines and use thereof
GB201416797D0 (en) Contianer and method of use thereof